REFERENCES REVIEWED FOR 2007 GINA UPDATE
Selected from PUB MED for the period July 1, 2006 through June 30, 2007
Criteria: Asthma, All Fields, items with abstracts, human, clinical trial and
Asthma AND systematic, All Fields, items with abstracts, human
1.
Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled
asthma. Am J Respir Crit Care Med 2007;175:235-42.
2.
Abreu Gonzalez J, Hernandez Garcia C, Abreu Gonzalez P, Martin Garcia C, Jimenez A.
[Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease
exacerbations requiring hospitalization: a randomized placebo-controlled trial]. Arch
Bronconeumol 2006;42:384-7.
3.
Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of
asthma. A multicentre population-based study. Int Arch Allergy Immunol 2006;141:189-98.
4.
Adams NP, Jones PW. The dose-response characteristics of inhaled corticosteroids when
used to treat asthma: an overview of Cochrane systematic reviews. Respir Med 2006;100:1297306.
5.
Adamzik M, Groeben H, Farahani R, Lehmann N, Peters J. Intravenous lidocaine after
tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesth Analg
2007;104:168-72.
6.
Ait-Khaled N, Enarson DA, Bencharif N, et al. Treatment outcome of asthma after one
year follow-up in health centres of several developing countries. Int J Tuberc Lung Dis
2006;10:911-6.
7.
Akerman MJ, Yaegashi M, Khiangte Z, Murugan AT, Abe O, Marmur JD.
Bronchodilator effect of infused B-type natriuretic peptide in asthma. Chest 2006;130:66-72.
8.
Akobeng AK, Heller RF. Assessing the population impact of low rates of breast feeding
on asthma, coeliac disease and obesity: the use of a new statistical method. Arch Dis Child
2007;92:483-5.
9.
Aldington S, Williams M, Weatherall M, Beasley R. Duration of action of the
salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled
trial in childhood asthma. Respirology 2006;11:638-42.
10.
Altamimi S, Robertson G, Jastaniah W, et al. Single-dose oral dexamethasone in the
emergency management of children with exacerbations of mild to moderate asthma. Pediatr
Emerg Care 2006;22:786-93.
11.
Altunc U, Pittler MH, Ernst E. Homeopathy for childhood and adolescence ailments:
systematic review of randomized clinical trials. Mayo Clin Proc 2007;82:69-75.
12.
Alvarez GG, Fitzgerald JM. A systematic review of the psychological risk factors
associated with near fatal asthma or fatal asthma. Respiration 2007;74:228-36.
13.
Amirav I, Yacobov R, Luder AS. Formoterol turbuhaler is as effective as salbutamol
diskus in relieving adenosine-induced bronchoconstriction in children. J Aerosol Med 2007;20:16.
14.
Andreasyan K, Ponsonby AL, Dwyer T, Dear K, Cochrane J. Infant feeding and
childhood atopy: does early introduction of non-milk fluids matter? Pediatr Allergy Immunol
2007;18:250-7.
15.
Anguita JL, Palacios L, Ruiz-Valenzuela L, et al. An occupational respiratory allergy
caused by Sinapis alba pollen in olive farmers. Allergy 2007;62:447-50.
16.
Anthracopoulos MB, Liolios E, Panagiotakos DB, Triantou K, Priftis KN. Prevalence of
asthma among schoolchildren in Patras, Greece: four questionnaire surveys during 1978-2003.
Arch Dis Child 2007;92:209-12.
17.
Antonicelli L, Micucci C, Voltolini S, et al. Allergic rhinitis and asthma comorbidity:
ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp
Allergy 2007;37:954-60.
18.
Antonicelli L, Micucci C, Voltolini S, et al. Relationship between ARIA classification
and drug treatment in allergic rhinitis and asthma. Allergy 2007;62:1064-70.
19.
Armentia A, Bartolome B, Puyo M, et al. Tobacco as an allergen in bronchial disease.
Ann Allergy Asthma Immunol 2007;98:329-36.
20.
Arnlind MH, Nokela M, Rehnberg C, Jonsson EW. The relationship between
pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish
primary care. J Asthma 2006;43:585-91.
21.
Arnold SR, Bush AJ. Decline in inappropriate antibiotic use over a decade by
pediatricians in a Tennessee community. Ambul Pediatr 2006;6:225-9.
22.
Arshad SH, Bateman B, Sadeghnejad A, Gant C, Matthews SM. Prevention of allergic
disease during childhood by allergen avoidance: the Isle of Wight prevention study. J Allergy
Clin Immunol 2007;119:307-13.
23.
Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of
symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One
and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43.
24.
Aslan S, Kandis H, Akgun M, Cakir Z, Inandi T, Gorguner M. The effect of nebulized
NaHCO3 treatment on "RADS" due to chlorine gas inhalation. Inhal Toxicol 2006;18:895-900.
25.
Backer V, Nepper-Christensen S, Nolte H. Quality of care in patients with asthma and
rhinitis treated by respiratory specialists and primary care physicians: a 3-year randomized and
prospective follow-up study. Ann Allergy Asthma Immunol 2006;97:490-6.
26.
Bakhireva LN, Jones KL, Schatz M, et al. Safety of leukotriene receptor antagonists in
pregnancy. J Allergy Clin Immunol 2007;119:618-25.
27.
Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ. Combined
mediator blockade or topical steroid for treating the unified allergic airway. Allergy 2007;62:7380.
28.
Basibuyuk T, Ozaydin E, Cengizlier R. Nasal cytology in the diagnosis and treatment of
sinusitis in atopic and nonatopic children. J Otolaryngol 2006;35:255-60.
29.
Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The
correlation between asthma control and health status: the GOAL study. Eur Respir J 2007;29:5662.
30.
Batra J, Pratap Singh T, Mabalirajan U, Sinha A, Prasad R, Ghosh B. Association of
inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood
eosinophil levels. Thorax 2007;62:16-22.
31.
Batra J, Sharma SK, Ghosh B. Arylamine N-acetyltransferase gene polymorphisms:
markers for atopic asthma, serum IgE and blood eosinophil counts. Pharmacogenomics
2006;7:673-82.
32.
Bavbek S, Dursun AB, Dursun E, Eryilmaz A, Misirligil Z. Safety of meloxicam in
aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. Int
Arch Allergy Immunol 2007;142:64-9.
33.
Beach J, Russell K, Blitz S, et al. A systematic review of the diagnosis of occupational
asthma. Chest 2007;131:569-78.
34.
Bell JS, Vaananen M, Ovaskainen H, Narhi U, Airaksinen MS. Providing patient care in
community pharmacies: practice and research in Finland. Ann Pharmacother 2007;41:1039-46.
35.
Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza
vaccine in infants and young children. N Engl J Med 2007;356:685-96.
36.
Bender BG, Long A, Parasuraman B, Tran ZV. Factors influencing patient decisions
about the use of asthma controller medication. Ann Allergy Asthma Immunol 2007;98:322-8.
37.
Berger WE, Milgrom H, Chervinsky P, et al. Effects of treatment with mometasone
furoate dry powder inhaler in children with persistent asthma. Ann Allergy Asthma Immunol
2006;97:672-80.
38.
Bernardini R, Campodonico P, Burastero S, et al. Sublingual immunotherapy with a latex
extract in paediatric patients: a double-blind, placebo-controlled study. Curr Med Res Opin
2006;22:1515-22.
39.
Bethke TD, Bohmer GM, Hermann R, et al. Dose-proportional intraindividual single- and
repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor.
J Clin Pharmacol 2007;47:26-36.
40.
Bethke TD, Giessmann T, Westphal K, et al. Roflumilast, a once-daily oral
phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled
salbutamol when co-administered in healthy subjects. Int J Clin Pharmacol Ther 2006;44:572-9.
41.
Bezarashvili B. [Effect of plaferon in children treated for bronchial asthma]. Georgian
Med News 2006:53-6.
42.
Bhogal S, Zemek R, Ducharme FM. Written action plans for asthma in children.
Cochrane Database Syst Rev 2006;3:CD005306.
43.
Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C.
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
Chest 2006;130:1733-43.
44.
Bleecker ER, Yancey SW, Baitinger LA, et al. Salmeterol response is not affected by
beta2-adrenergic receptor genotype in subjects with persistent asthma. J Allergy Clin Immunol
2006;118:809-16.
45.
Blumberga G, Groes L, Haugaard L, Dahl R. Steroid-sparing effect of subcutaneous SQstandardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics.
Allergy 2006;61:843-8.
46.
Boot JD, de Haas S, Tarasevych S, et al. Effect of an NK1/NK2 receptor antagonist on
airway responses and inflammation to allergen in asthma. Am J Respir Crit Care Med
2007;175:450-7.
47.
Boot JD, de Kam ML, Mascelli MA, et al. Nasal nitric oxide: longitudinal reproducibility
and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy
2007;62:378-84.
48.
Borderias L, Mincewicz G, Paggiaro PL, et al. Asthma control in patients with asthma
and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective
observational study. Curr Med Res Opin 2007;23:721-30.
49.
Boutet K, Malo JL, Ghezzo H, Gautrin D. Airway hyperresponsiveness and risk of chest
symptoms in an occupational model. Thorax 2007;62:260-4.
50.
Brachlow AE, Ness KK, McPheeters ML, Gurney JG. Comparison of indicators for a
primary care medical home between children with autism or asthma and other special health care
needs: National Survey of Children's Health. Arch Pediatr Adolesc Med 2007;161:399-405.
51.
Bradshaw LM, Barber CM, Davies J, Curran AD, Fishwick D. Work-related asthma
symptoms and attitudes to the workplace. Occup Med (Lond) 2007;57:30-5.
52.
Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B. The
safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway
hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res
2005;6:144.
53.
Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric
oxide in patients with asthma of differing severity. Chest 2007;131:1353-62.
54.
Brown MD, Reeves MJ, Meyerson K, Korzeniewski SJ. Randomized trial of a
comprehensive asthma education program after an emergency department visit. Ann Allergy
Asthma Immunol 2006;97:44-51.
55.
Brown RH, Pearse DB, Pyrgos G, Liu MC, Togias A, Permutt S. The structural basis of
airways hyperresponsiveness in asthma. J Appl Physiol 2006;101:30-9.
56.
Bruce CT, Zhao D, Yates DH, Thomas PS. AMP challenge induces a decrease in FE(NO)
in asthmatic subjects modulated by nedocromil. Eur J Clin Invest 2006;36:899-905.
57.
Bruzzese JM, Evans D, Wiesemann S, et al. Using school staff to establish a preventive
network of care to improve elementary school students' control of asthma. J Sch Health
2006;76:307-12.
58.
Buchele G, Rzehak P, Weinmayr G, et al. Assessing bronchial responsiveness to
hypertonic saline using the stepwise protocol of Phase Two of the International Study of Asthma
and Allergies in Childhood (ISAAC II). Pediatr Pulmonol 2007;42:131-40.
59.
Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD. A randomized clinical
trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care
Med 2006;174:1077-87.
60.
Bullens DM, Truyen E, Coteur L, et al. IL-17 mRNA in sputum of asthmatic patients:
linking T cell driven inflammation and granulocytic influx? Respir Res 2006;7:135.
61.
Burkhart PV, Rayens MK, Revelette WR, Ohlmann A. Improved health outcomes with
peak flow monitoring for children with asthma. J Asthma 2007;44:137-42.
62.
Burki NK, Alam M, Lee LY. The pulmonary effects of intravenous adenosine in
asthmatic subjects. Respir Res 2006;7:139.
63.
Cai C, Yang J, Hu S, Zhou M, Guo W. Relationship between urinary cysteinyl
leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma.
Lung 2007;185:105-12.
64.
Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in
asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration
method. Allergy 2006;61:1162-72.
65.
Can M, Yuksel B, Demirtas S, Tomac N. The effect of montelukast on soluble
interleukin-2 receptor and tumor necrosis factor alpha in pediatric asthma. Allergy Asthma Proc
2006;27:383-6.
66.
Capra V, Thompson MD, Sala A, Cole DE, Folco G, Rovati GE. Cysteinyl-leukotrienes
and their receptors in asthma and other inflammatory diseases: critical update and emerging
trends. Med Res Rev 2007;27:469-527.
67.
Capraz F, Kunter E, Cermik H, Ilvan A, Pocan S. The effect of inhaled budesonide and
formoterol on bronchial remodeling and HRCT features in young asthmatics. Lung 2007;185:8996.
68.
Carlsten C, Aitken ML, Hallstrand TS. Safety of sputum induction with hypertonic saline
solution in exercise-induced bronchoconstriction. Chest 2007;131:1339-44.
69.
Celikel S, Karakaya G, Yurtsever N, Sorkun K, Kalyoncu AF. Bee and bee products
allergy in Turkish beekeepers: determination of risk factors for systemic reactions. Allergol
Immunopathol (Madr) 2006;34:180-4.
70.
Chakraborti A, Lodha R, Pandey RM, Kabra SK. Randomized controlled trial of
ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation
of asthma. Indian J Pediatr 2006;73:979-83.
71.
Chan CK, Kuo ML, Shen JJ, See LC, Chang HH, Huang JL. Ding Chuan Tang, a
Chinese herb decoction, could improve airway hyper-responsiveness in stabilized asthmatic
children: a randomized, double-blind clinical trial. Pediatr Allergy Immunol 2006;17:316-22.
72.
Chan DS, Callahan CW, Hatch-Pigott VB, et al. Internet-based home monitoring and
education of children with asthma is comparable to ideal office-based care: results of a 1-year
asthma in-home monitoring trial. Pediatrics 2007;119:569-78.
73.
Chan IH, Tang NL, Leung TF, et al. Association of prostaglandin-endoperoxide synthase
2 gene polymorphisms with asthma and atopy in Chinese children. Allergy 2007;62:802-9.
74.
Charles T, Quinn D, Weatherall M, Aldington S, Beasley R, Holt S. An audiovisual
reminder function improves adherence with inhaled corticosteroid therapy in asthma. J Allergy
Clin Immunol 2007;119:811-6.
75.
Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung
function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med
2006;174:127-33.
76.
Cheng YX, Foster B, Holland SM, et al. CD2 identifies a monocyte subpopulation with
immunoglobulin E-dependent, high-level expression of Fc epsilon RI. Clin Exp Allergy
2006;36:1436-45.
77.
Chinchilli VM. General principles for systematic reviews and meta-analyses and a
critique of a recent systematic review of long-acting beta-agonists. J Allergy Clin Immunol
2007;119:303-6.
78.
Chinn S, Downs SH, Anto JM, et al. Incidence of asthma and net change in symptoms in
relation to changes in obesity. Eur Respir J 2006;28:763-71.
79.
Choudhry S, Burchard EG, Borrell LN, et al. Ancestry-environment interactions and
asthma risk among Puerto Ricans. Am J Respir Crit Care Med 2006;174:1088-93.
80.
Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in
improving adherence to medicines. Pharm World Sci 2006;28:165-70.
81.
Cobaugh DJ, Krenzelok EP. Adverse drug reactions and therapeutic errors in older
adults: a hazard factor analysis of poison center data. Am J Health Syst Pharm 2006;63:2228-34.
82.
Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Incidence of IBS in a cohort of
people with asthma. Dig Dis Sci 2007;52:329-35.
83.
Colebourn CL, Barber V, Young JD. Use of helium-oxygen mixture in adult patients
presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic
review. Anaesthesia 2007;62:34-42.
84.
Correll PK, Xuan W, Williamson M, Sundararajan V, Ringland C, Marks GB.
Reattendance at hospital for asthma in two Australian states, 2000-2003. Respirology
2007;12:220-6.
85.
Corsico AG, Cazzoletti L, de Marco R, et al. Factors affecting adherence to asthma
treatment in an international cohort of young and middle-aged adults. Respir Med
2007;101:1363-7.
86.
Corver K, Kerkhof M, Brussee JE, et al. House dust mite allergen reduction and allergy
at 4 yr: follow up of the PIAMA-study. Pediatr Allergy Immunol 2006;17:329-36.
87.
Couderc L. [Why asthma remains undertreated? Evidence to support one's argument].
Arch Pediatr 2007;14:694-5.
88.
Cox G, Thomson NC, Rubin AS, et al. Asthma control during the year after bronchial
thermoplasty. N Engl J Med 2007;356:1327-37.
89.
Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir
Med 2006;100:1307-17.
90.
Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R. EXCEL: A randomised trial
comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults
with persistent asthma. Respir Med 2006;100:1152-62.
91.
de Benedictis FM, del Giudice MM, Forenza N, Decimo F, de Benedictis D, Capristo A.
Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction
in children. Eur Respir J 2006;28:291-5.
92.
de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary
disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J
Respir Crit Care Med 2007;175:32-9.
93.
de Vries MP, van den Bemt L, Aretz K, et al. House dust mite allergen avoidance and
self-management in allergic patients with asthma: randomised controlled trial. Br J Gen Pract
2007;57:184-90.
94.
Del-Rio-Navarro B, Berber A, Blandon-Vijil V, et al. Identification of asthma risk factors
in Mexico City in an International Study of Asthma and Allergy in Childhood survey. Allergy
Asthma Proc 2006;27:325-33.
95.
Del-Rio-Navarro B, Berber A, Blandon-Vijil V, et al. Identification of asthma risk factors
in Mexico City in an International Study of Asthma and Allergy in Childhood survey. Allergy
Asthma Proc 2006;27:325-33.
96.
Del-Rio-Navarro B, Del Rio-Chivardi JM, Berber A, Sienra-Monge JJ, Rosas-Vargas
MA, Baeza-Bacab M. Asthma prevalence in children living in north Mexico City and a
comparison with other Latin American cities and world regions. Allergy Asthma Proc
2006;27:334-40.
97.
Dewilde S, Turk F, Tambour M, Sandstrom T. The economic value of anti-IgE in severe
persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden. Curr
Med Res Opin 2006;22:1765-76.
98.
Deykin A, Wechsler ME, Boushey HA, et al. Combination therapy with a long-acting
beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med
2007;175:228-34.
99.
Di Rienzo V, Minelli M, Sambugaro R, et al. Applicability of extracellular electrical
impedance tomography in monitoring respiratory tract inflammation. J Investig Allergol Clin
Immunol 2007;17:34-8.
100. Dixon AE, Kaminsky DA, Holbrook JT, Wise RA, Shade DM, Irvin CG. Allergic rhinitis
and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest
2006;130:429-35.
101. Dixon AE, Shade DM, Cohen RI, et al. Effect of obesity on clinical presentation and
response to treatment in asthma. J Asthma 2006;43:553-8.
102. Dixon AE, Yeh F, Welty TK, et al. Asthma in American Indian adults: the Strong Heart
Study. Chest 2007;131:1323-30.
103. Dorsey MJ, Cohen LE, Phipatanakul W, Denufrio D, Schneider LC. Assessment of
adrenal suppression in children with asthma treated with inhaled corticosteroids: use of
dehydroepiandrosterone sulfate as a screening test. Ann Allergy Asthma Immunol 2006;97:1826.
104. Duong M, Gauvreau G, Watson R, et al. The effects of inhaled budesonide and
formoterol in combination and alone when given directly after allergen challenge. J Allergy Clin
Immunol 2007;119:322-7.
105. Duse M, Donato F, Porteri V, et al. High prevalence of atopy, but not of asthma, among
children in an industrialized area in North Italy: the role of familial and environmental factors--a
population-based study. Pediatr Allergy Immunol 2007;18:201-8.
106. Duvvuri VR, Jianhong W. Information and communication technology developments in
asthma management: a systematic review. Indian J Med Sci 2007;61:221-41.
107. El Miedany Y, Youssef S, Ahmed I, El Gaafary M. Safety of etoricoxib, a specific
cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
Ann Allergy Asthma Immunol 2006;97:105-9.
108. Epton MJ, Town GI, Ingham T, Wickens K, Fishwick D, Crane J. The New Zealand
Asthma and Allergy Cohort Study (NZA2CS): assembly, demographics and investigations. BMC
Public Health 2007;7:26.
109. Ercan H, Birben E, Dizdar EA, et al. Oxidative stress and genetic and epidemiologic
determinants of oxidant injury in childhood asthma. J Allergy Clin Immunol 2006;118:1097-104.
110. Erin EM, Leaker BR, Nicholson GC, et al. The effects of a monoclonal antibody directed
against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 2006;174:753-62.
111. Ernst P, Franssen E, Chan CK, Okell M, O'Byrne P, Bai T. Predictors of a more
favourable response to combined therapy with salmeterol and fluticasone as initial maintenance
therapy in asthma. Respir Med 2007.
112. Esposito-Festen J, Ijsselstijn H, Hop W, van Vliet F, de Jongste J, Tiddens H. Aerosol
therapy by pressured metered-dose inhaler-spacer in sleeping young children: to do or not to do?
Chest 2006;130:487-92.
113. Ezratty V, Bonay M, Neukirch C, et al. Effect of formaldehyde on asthmatic response to
inhaled allergen challenge. Environ Health Perspect 2007;115:210-4.
114. Farkhutdinov UR. [Intravascular laser irradiation of blood in the treatment of patients
with bronchial asthma]. Ter Arkh 2007;79:44-8.
115. Feldman JM, McQuaid EL, Klein RB, et al. Symptom perception and functional
morbidity across a 1-year follow-up in pediatric asthma. Pediatr Pulmonol 2007;42:339-47.
116. Feltis BN, Wignarajah D, Reid DW, Ward C, Harding R, Walters EH. Effects of inhaled
fluticasone on angiogenesis and vascular endothelial growth factor in asthma. Thorax
2007;62:314-9.
117. Ferguson AC, Van Bever HP, Teper AM, Lasytsya O, Goldfrad CH, Whitehead PJ. A
comparison of the relative growth velocities with budesonide and fluticasone propionate in
children with asthma. Respir Med 2007;101:118-29.
118. Ferraz E, Borges MC, Terra-Filho J, Martinez JA, Vianna EO. Comparison of 4 AM and
4 PM bronchial responsiveness to hypertonic saline in asthma. Lung 2006;184:341-6.
119. Fishwick D, Bradshaw L, Henson M, et al. Occupational asthma: an assessment of
diagnostic agreement between physicians. Occup Environ Med 2007;64:185-90.
120. Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live
attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus
vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006;25:860-9.
121. Fleming L, Wilson N, Bush A. Difficult to control asthma in children. Curr Opin Allergy
Clin Immunol 2007;7:190-5.
122. Fonseca-Aten M, Okada PJ, Bowlware KL, et al. Effect of clarithromycin on cytokines
and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind,
randomized, placebo-controlled trial. Ann Allergy Asthma Immunol 2006;97:457-63.
123. Foster JM, Aucott L, van der Werf RH, et al. Higher patient perceived side effects related
to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis.
Respir Med 2006;100:1318-36.
124. Foster JM, Hoskins G, Smith B, Lee AJ, Price D, Pinnock H. Practice development plans
to improve the primary care management of acute asthma: randomised controlled trial. BMC
Fam Pract 2007;8:23.
125. Foster JM, van Sonderen E, Lee AJ, et al. A self-rating scale for patient-perceived side
effects of inhaled corticosteroids. Respir Res 2006;7:131.
126. Fritsch M, Uxa S, Horak F, Jr., et al. Exhaled nitric oxide in the management of
childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006;41:855-62.
127. Fueyo A, Ruiz MA, Ancochea J, Guilera M, Badia X. Asthma control in Spain. Do
season and treatment pattern matter? The ESCASE study. Respir Med 2007;101:919-24.
128. Fujimoto K, Komatsu Y, Yasuo M, Urushihata K, Kubo K. Comparison of the clinical
efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled
asthma patients on inhaled corticosteroids. J Asthma 2006;43:501-7.
129. Fujimoto K, Yamaguchi S, Urushibata K, et al. Characteristics of asthma resistant to
moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness. Intern Med
2006;45:843-9.
130. Garcia-Marcos L, Canflanca IM, Garrido JB, et al. Relationship of asthma and
rhinoconjunctivitis with obesity, exercise and Mediterranean diet in Spanish schoolchildren.
Thorax 2007;62:503-8.
131. Garcia-Robaina JC, Sanchez I, de la Torre F, Fernandez-Caldas E, Casanovas M.
Successful management of mite-allergic asthma with modified extracts of Dermatophagoides
pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study. J
Allergy Clin Immunol 2006;118:1026-32.
132. Gaston B, Kelly R, Urban P, et al. Buffering airway acid decreases exhaled nitric oxide in
asthma. J Allergy Clin Immunol 2006;118:817-22.
133. Gerald LB, Redden D, Wittich AR, et al. Outcomes for a comprehensive school-based
asthma management program. J Sch Health 2006;76:291-6.
134. Gessner BD, Chimonas MA. Asthma is associated with preterm birth but not with small
for gestational age status among a population-based cohort of Medicaid-enrolled children <10
years of age. Thorax 2007;62:231-6.
135. Ghosh G, Manglik AK, Roy S. Efficacy and safety of montelukast as monotherapy in
children with mild persistent asthma. Indian Pediatr 2006;43:780-5.
136. Gibson PG, Powell H, Ducharme FM. Differential effects of maintenance long-acting
beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy
Clin Immunol 2007;119:344-50.
137. Gilliland FD, Li YF, Gong H, Jr., Diaz-Sanchez D. Glutathione s-transferases M1 and P1
prevent aggravation of allergic responses by secondhand smoke. Am J Respir Crit Care Med
2006;174:1335-41.
138. Gontijo-Amaral C, Ribeiro MA, Gontijo LS, Condino-Neto A, Ribeiro JD. Oral
magnesium supplementation in asthmatic children: a double-blind randomized placebocontrolled trial. Eur J Clin Nutr 2007;61:54-60.
139. Goodyer L, Savage I, Dikmen Z. Inhaler technique in Turkish people with poor English:
a case of information discrimination? Pharm World Sci 2006;28:107-14.
140. Grimm DR, Schilero GJ, Spungen AM, Bauman WA, Lesser M. Salmeterol improves
pulmonary function in persons with tetraplegia. Lung 2006;184:335-9.
141. Guan XJ, Zhang WX, Li CC, et al. [The role of external signal regulated kinase and
transforming growth factor beta(1) in asthma airway remodeling and regulation of
glucocorticoids]. Zhonghua Yi Xue Za Zhi 2007;87:1767-72.
142. Gupta K, Vohra V, Sood J. The role of magnesium as an adjuvant during general
anaesthesia. Anaesthesia 2006;61:1058-63.
143. Gvozdenovic BS, Zugic V, Lapcevic M, et al. [Relationship between respiratory
symptoms and satisfaction with inhaled asthma medication]. Srp Arh Celok Lek 2006;134:498502.
144. Gyllfors P, Dahlen SE, Kumlin M, Larsson K, Dahlen B. Bronchial responsiveness to
leukotriene D4 is resistant to inhaled fluticasone propionate. J Allergy Clin Immunol
2006;118:78-83.
145. Haahtela T, Tamminen K, Malmberg LP, et al. Formoterol as needed with or without
budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA
study. Eur Respir J 2006;28:748-55.
146. Halterman JS, Fisher S, Conn KM, et al. Improved preventive care for asthma: a
randomized trial of clinician prompting in pediatric offices. Arch Pediatr Adolesc Med
2006;160:1018-25.
147. Halterman JS, Kitzman H, McMullen A, et al. Quantifying preventive asthma care
delivered at office visits: the Preventive Asthma Care-Composite Index (PAC-CI). J Asthma
2006;43:559-64.
148. Halterman JS, Yoos HL, Kitzman H, Anson E, Sidora-Arcoleo K, McMullen A.
Symptom reporting in childhood asthma: a comparison of assessment methods. Arch Dis Child
2006;91:766-70.
149. Hanania NA, Moore RH, Zimmerman JL, et al. The role of intrinsic efficacy in
determining response to a beta2-agonist in acute severe asthma. Respir Med 2007;101:1007-14.
150. Haney S, Hancox RJ. Overcoming beta-agonist tolerance: high dose salbutamol and
ipratropium bromide. Two randomised controlled trials. Respir Res 2007;8:19.
151. Harris RS, Winkler T, Tgavalekos N, et al. Regional pulmonary perfusion, inflation, and
ventilation defects in bronchoconstricted patients with asthma. Am J Respir Crit Care Med
2006;174:245-53.
152. Harrold LR, Patterson MK, Andrade SE, et al. Asthma drug use and the development of
Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf 2007;16:620-6.
153. Hartmann CW, Sciamanna CN, Blanch DC, et al. A website to improve asthma care by
suggesting patient questions for physicians: qualitative analysis of user experiences. J Med
Internet Res 2007;9:e3.
154. Haruta S, Okayama M, Uchida T, Hirosawa K, Kasanuki H. Airway hyperresponsiveness
in patients with coronary spastic angina: relationship between coronary spasticity and airway
responsiveness. Circ J 2007;71:234-41.
155. Haughney J, Cotton P, Rosen JP, Morrison K, Price D. The use of a modification of the
Patient Enablement Instrument in asthma. Prim Care Respir J 2007;16:89-92.
156. Hederos CA, Janson S, Hedlin G. A gender perspective on parents' answers to a
questionnaire on children's asthma. Respir Med 2007;101:554-60.
157. Hellgren J, Omenaas E, Gislason T, et al. Perennial non-infectious rhinitis--an
independent risk factor for sleep disturbances in Asthma. Respir Med 2007;101:1015-20.
158. Horiguchi T, Hayashi N, Ohira D, et al. Usefulness of HFA-BDP for adult patients with
bronchial asthma: randomized crossover study with fluticasone. J Asthma 2006;43:509-12.
159. Horiguchi T, Tachikawa S, Kondo R, et al. Comparative evaluation of the leukotriene
receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged
patients with mild bronchial asthma. Arzneimittelforschung 2007;57:87-91.
160. Iino Y, Nagamine H, Kakizaki K, et al. Effectiveness of instillation of triamcinolone
acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann
Allergy Asthma Immunol 2006;97:761-6.
161. Illi S, von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U. Perennial allergen
sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet
2006;368:763-70.
162. Inal A, Altintas DU, Yilmaz M, Karakoc GB, Kendirli SG, Sertdemir Y. Prevention of
new sensitizations by specific immunotherapy in children with rhinitis and/or asthma
monosensitized to house dust mite. J Investig Allergol Clin Immunol 2007;17:85-91.
163. Jaakkola JJ, Ahmed P, Ieromnimon A, et al. Preterm delivery and asthma: a systematic
review and meta-analysis. J Allergy Clin Immunol 2006;118:823-30.
164. Jaakkola MS, Jaakkola JJ. Impact of smoke-free workplace legislation on exposures and
health: possibilities for prevention. Eur Respir J 2006;28:397-408.
165. Jamalvi SW, Raza SJ, Naz F, Shamim S, Jamalvi SM. Management of acute asthma in
children using metered dose inhaler and small volume nebulizer. J Pak Med Assoc 2006;56:5959.
166. Jantikar A, Brashier B, Maganji M, et al. Comparison of bronchodilator responses of
levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized,
double blind, single-dose, crossover study. Respir Med 2007;101:845-9.
167. Jarjour NN, Wilson SJ, Koenig SM, et al. Control of airway inflammation maintained at a
lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. J Allergy Clin
Immunol 2006;118:44-52.
168. Jat GC, Mathew JL, Singh M. Treatment with 400 microg of inhaled budesonide vs 200
microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma:
randomized controlled trial. Ann Allergy Asthma Immunol 2006;97:397-401.
169. Jeyakumar A, Brickman TM, Haben M. Effectiveness of amitriptyline versus cough
suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy.
Laryngoscope 2006;116:2108-12.
170. Johnson JB, Summer W, Cutler RG, et al. Alternate day calorie restriction improves
clinical findings and reduces markers of oxidative stress and inflammation in overweight adults
with moderate asthma. Free Radic Biol Med 2007;42:665-74.
171. Jonkers RE, Bantje TA, Aalbers R. Onset of relief of dyspnoea with
budesonide/formoterol or salbutamol following methacholine-induced severe
bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. Respir Res
2006;7:141.
172. Joseph CL, Peterson E, Havstad S, et al. A web-based, tailored asthma management
program for urban African-American high school students. Am J Respir Crit Care Med
2007;175:888-95.
173. Kabesch M, Depner M, Dahmen I, et al. Polymorphisms in eosinophil pathway genes,
asthma and atopy. Allergy 2007;62:423-8.
174. Kaditis AG, Winnie G, Syrogiannopoulos GA. Anti-inflammatory pharmacotherapy for
wheezing in preschool children. Pediatr Pulmonol 2007;42:407-20.
175. Kamchaisatian W, Wanwatsuntikul W, Sleasman JW, Tangsinmankong N. Validation of
current joint American Academy of Allergy, Asthma & Immunology and American College of
Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent
pneumococcal vaccine using a population of HIV-infected children. J Allergy Clin Immunol
2006;118:1336-41.
176. Kanazawa H, Nomura S, Asai K. Roles of angiopoietin-1 and angiopoietin-2 on airway
microvascular permeability in asthmatic patients. Chest 2007;131:1035-41.
177. Karadag B, Ege M, Bradley JE, et al. The role of parasitic infections in atopic diseases in
rural schoolchildren. Allergy 2006;61:996-1001.
178. Karnick P, Margellos-Anast H, Seals G, Whitman S, Aljadeff G, Johnson D. The
pediatric asthma intervention: a comprehensive cost-effective approach to asthma management
in a disadvantaged inner-city community. J Asthma 2007;44:39-44.
179. Karpel JP, Nayak A, Lumry W, et al. Inhaled mometasone furoate reduces oral
prednisone usage and improves lung function in severe persistent asthma. Respir Med
2007;101:628-37.
180. Kawakami T, Kaminishi K, Soma Y, Kushimoto T, Mizoguchi M. Oral antihistamine
therapy influences plasma tryptase levels in adult atopic dermatitis. J Dermatol Sci 2006;43:12734.
181. Kelly AM, Clooney M. Improving asthma discharge management in relation to
emergency departments: The ADMIRE project. Emerg Med Australas 2007;19:59-62.
182. Kelly MM, Chakir J, Vethanayagam D, et al. Montelukast treatment attenuates the
increase in myofibroblasts following low-dose allergen challenge. Chest 2006;130:741-53.
183. Kercsmar CM, Dearborn DG, Schluchter M, et al. Reduction in asthma morbidity in
children as a result of home remediation aimed at moisture sources. Environ Health Perspect
2006;114:1574-80.
184. Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Sackesen C, Kalayci O. The effects of
grass pollen allergoid immunotherapy on clinical and immunological parameters in children with
allergic rhinitis. Pediatr Allergy Immunol 2006;17:396-407.
185. Khan Y, Tang Y, Hochhaus G, et al. Lung bioavailability of hydrofluoroalkane
fluticasone in young children when delivered by an antistatic chamber/mask. J Pediatr
2006;149:793-7.
186. Khoshoo V, Haydel R, Jr. Effect of antireflux treatment on asthma exacerbations in
nonatopic children. J Pediatr Gastroenterol Nutr 2007;44:331-5.
187. Kida K, Wakabayashi R, Mizuuchi T, Murata A. Screening for suspected chronic
obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q). Intern
Med 2006;45:1201-7.
188. Kiechl-Kohlendorfer U, Horak E, Mueller W, et al. Living at high altitude and risk of
hospitalisation for atopic asthma in children: results from a large prospective birth-cohort study.
Arch Dis Child 2007;92:339-42.
189. Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE. Serum eosinophil-derived
neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in
childhood asthma. Lung 2007;185:97-103.
190. Klotsman M, York TP, Pillai SG, et al. Pharmacogenetics of the 5-lipoxygenase
biosynthetic pathway and variable clinical response to montelukast. Pharmacogenet Genomics
2007;17:189-96.
191. Klusackova P, Lebedova J, Pelclova D, Salandova J, Senholdova Z, Navratil T.
Occupational asthma and rhinitis in workers from a lasamide production line. Scand J Work
Environ Health 2007;33:74-8.
192. Kobayashi Y, Yasuba H, Kudou M, Kita H. Addition of transdermal or inhaled longacting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover
study from tulobuterol patch to salmeterol dry powder inhaler. J Asthma 2007;44:77-81.
193. Kodric M, Shah AN, Fabbri LM, Confalonieri M. An investigation of airway
acidification in asthma using induced sputum: a study of feasibility and correlation. Am J Respir
Crit Care Med 2007;175:905-10.
194. Koh GC, Shek LP, Goh DY, Van Bever H, Koh DS. Eosinophil cationic protein: is it
useful in asthma? A systematic review. Respir Med 2007;101:696-705.
195. Kolpakova AF. [Effects of combined therapy with domestic inhalational anti-asthmatic
drugs on oxidant status of patients with bronchial asthma]. Ter Arkh 2007;79:41-4.
196. Kondo N, Katsunuma T, Odajima Y, Morikawa A. A randomized open-label comparative
study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children.
Allergol Int 2006;55:287-93.
197. Kools M, van de Wiel MW, Ruiter RA, Cruts A, Kok G. The effect of graphic organizers
on subjective and objective comprehension of a health education text. Health Educ Behav
2006;33:760-72.
198. Kools M, van de Wiel MW, Ruiter RA, Kok G. Pictures and text in instructions for
medical devices: effects on recall and actual performance. Patient Educ Couns 2006;64:104-11.
199. Kozyrskyj AL, Dahl ME, Ungar WJ, Becker AB, Law BJ. Antibiotic treatment of
wheezing in children with asthma: what is the practice? Pediatrics 2006;117:e1104-10.
200. Kraft M, Cairns CB, Ellison MC, Pak J, Irvin C, Wenzel S. Improvements in distal lung
function correlate with asthma symptoms after treatment with oral montelukast. Chest
2006;130:1726-32.
201. Krishnan V, Diette GB, Rand CS, et al. Mortality in patients hospitalized for asthma
exacerbations in the United States. Am J Respir Crit Care Med 2006;174:633-8.
202. Kritikos V, Armour CL, Bosnic-Anticevich SZ. Interactive small-group asthma education
in the community pharmacy setting: a pilot study. J Asthma 2007;44:57-64.
203. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebocontrolled trial. J Allergy Clin Immunol 2007;119:192-8.
204. Kull I, Bergstrom A, Melen E, et al. Early-life supplementation of vitamins A and D, in
water-soluble form or in peanut oil, and allergic diseases during childhood. J Allergy Clin
Immunol 2006;118:1299-304.
205. Kumar R, Singh BP, Srivastava P, Sridhara S, Arora N, Gaur SN. Relevance of serum
IgE estimation in allergic bronchial asthma with special reference to food allergy. Asian Pac J
Allergy Immunol 2006;24:191-9.
206. Kuna P, Creemers JP, Vondra V, et al. Once-daily dosing with budesonide/formoterol
compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild
to moderate asthma. Respir Med 2006;100:2151-9.
207. Kupczyk M, Kuprys I, Gorski P, Kuna P. The effect of montelukast (10mg daily) and
loratadine (10mg daily) on wheal, flare and itching reactions in skin prick tests. Pulm Pharmacol
Ther 2007;20:85-9.
208. La Grutta S, Arena A, D'Anneo WR, et al. Evaluation of the antiinflammatory and
clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with
or without rhinitis. A 12-month perspective randomized, controlled, trial. Allerg Immunol (Paris)
2007;39:40-4.
209. Labrecque M, Lavallee M, Beauchesne MF, Cartier A, Boulet LP. Can access to
spirometry in asthma education centres influence the referral rate by primary physicians for
education? Can Respir J 2006;13:427-31.
210. Lafond C, Series F, Lemiere C. Impact of CPAP on asthmatic patients with obstructive
sleep apnoea. Eur Respir J 2007;29:307-11.
211. Lancsar EJ, Hall JP, King M, et al. Using discrete choice experiments to investigate
subject preferences for preventive asthma medication. Respirology 2007;12:127-36.
212. Landis SE, Gaynes BN, Morrissey JP, Vinson N, Ellis AR, Domino ME. Generalist care
managers for the treatment of depressed medicaid patients in North Carolina: a pilot study. BMC
Fam Pract 2007;8:7.
213. Laufenberg-Horstmann E, DeVore E, Bassuener K. The Coulee Region Community
Pharmacy Asthma Intervention study. J Am Pharm Assoc (2003) 2006;46:738-46; quiz 46-7.
214. Lavorini F, Geri P, Mariani L, et al. Speed of onset of bronchodilator response to
salbutamol inhaled via different devices in asthmatics: a bioassay based on functional
antagonism. Br J Clin Pharmacol 2006;62:403-11.
215. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled
corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med
2007;175:783-90.
216. Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin
desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin
Immunol 2007;119:157-64.
217. Lee YL, Hwang BF, Lin YC, Guo YL. Time trend of asthma prevalence among school
children in Taiwan: ISAAC phase I and III surveys. Pediatr Allergy Immunol 2007;18:188-95.
218. Lehtinen P, Ruohola A, Vanto T, Vuorinen T, Ruuskanen O, Jartti T. Prednisolone
reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or
eczema. J Allergy Clin Immunol 2007;119:570-5.
219. Leonardi-Bee J, Pritchard D, Britton J. Asthma and current intestinal parasite infection:
systematic review and meta-analysis. Am J Respir Crit Care Med 2006;174:514-23.
220. Levy M, Heffner B, Stewart T, Beeman G. The efficacy of asthma case management in
an urban school district in reducing school absences and hospitalizations for asthma. J Sch
Health 2006;76:320-4.
221. Leynaert B, Guilloud-Bataille M, Soussan D, et al. Association between farm exposure
and atopy, according to the CD14 C-159T polymorphism. J Allergy Clin Immunol
2006;118:658-65.
222. Li CC, Guan XJ, Zhang WX, et al. [Role of external signal regulated kinase signal
transduction pathway in airway remodeling of rats with asthma and regulation by
glucocorticoids]. Zhonghua Er Ke Za Zhi 2007;45:288-92.
223. Liccardi G, Piccolo A, Dente B, et al. Rabbit allergens: a significant risk for allergic
sensitization in subjects without occupational exposure. Respir Med 2007;101:333-9.
224. Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the
Childhood Asthma Control Test. J Allergy Clin Immunol 2007;119:817-25.
225. Livingston E, Chaudhuri R, McMahon AD, Fraser I, McSharry CP, Thomson NC.
Systemic sensitivity to corticosteroids in smokers with asthma. Eur Respir J 2007;29:64-71.
226. Lloyd A, Price D, Brown R. The impact of asthma exacerbations on health-related quality
of life in moderate to severe asthma patients in the UK. Prim Care Respir J 2007;16:22-7.
227. Loke TK, Mallett KH, Ratoff J, et al. Systemic glucocorticoid reduces bronchial mucosal
activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoidresistant asthmatic patients. J Allergy Clin Immunol 2006;118:368-75.
228. Lomia M, Tchelidze T, Pruidze M. Bronchial asthma as neurogenic paroxysmal
inflammatory disease: a randomized trial with carbamazepine. Respir Med 2006;100:1988-96.
229. Lomia M, Tchelidze T, Pruidze M. Bronchial asthma as neurogenic paroxysmal
inflammatory disease: a randomized trial with carbamazepine. Respir Med 2006;100:1988-96.
230. Lotvall J, Langley S, Woodcock A. Inhaled steroid/long-acting beta 2 agonist
combination products provide 24 hours improvement in lung function in adult asthmatic patients.
Respir Res 2006;7:110.
231. Loyo-Berrios NI, Orengo JC, Serrano-Rodriguez RA. Childhood asthma prevalence in
northern Puerto Rico, the Rio Grande, and Loiza experience. J Asthma 2006;43:619-24.
232. Lue KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC. Clinical and immunologic
effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind,
randomized, placebo-controlled study. Pediatr Allergy Immunol 2006;17:408-15.
233. Ly F, Mbaye I, Wone I, et al. [Allergy to latex gloves among healthcare workers in
Dakar]. Ann Dermatol Venereol 2006;133:971-4.
234. Mak JC, Ko FW, Chu CM, et al. Polymorphisms in the IL-4, IL-4 receptor alpha chain,
TNF-alpha, and lymphotoxin-alpha genes and risk of asthma in Hong Kong Chinese adults. Int
Arch Allergy Immunol 2007;144:114-22.
235. Makino S, Adachi M, Ohta K, et al. A prospective survey on safety of sustained-release
theophylline in treatment of asthma and COPD. Allergol Int 2006;55:395-402.
236. Mallol J, Aguirre V. Once versus twice daily budesonide metered-dose inhaler in children
with mild to moderate asthma: effect on symptoms and bronchial responsiveness. Allergol
Immunopathol (Madr) 2007;35:25-31.
237. Manocha R. Sahaja yoga in asthma. Thorax 2003;58:825-6.
238. Marguet C. [Management of acute asthma in infants and children: recommendations from
the French Pediatric Society of Pneumology and Allergy]. Rev Mal Respir 2007;24:427-39.
239. Marinho S, Simpson A, Lowe L, Kissen P, Murray C, Custovic A. Rhinoconjunctivitis in
5-year-old children: a population-based birth cohort study. Allergy 2007;62:385-93.
240. Marks GB, Mihrshahi S, Kemp AS, et al. Prevention of asthma during the first 5 years of
life: a randomized controlled trial. J Allergy Clin Immunol 2006;118:53-61.
241. Martens JD, Winkens RA, van der Weijden T, de Bruyn D, Severens JL. Does a joint
development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a
pre/post study with concurrent control group and a randomised trial. BMC Health Serv Res
2006;6:145.
242. Martin RJ, Szefler SJ, King TS, et al. The Predicting Response to Inhaled Corticosteroid
Efficacy (PRICE) trial. J Allergy Clin Immunol 2007;119:73-80.
243. Masoli M, Weatherall M, Holt S, Shirtcliffe P, Beasley R. Inhaled fluticasone propionate
and adrenal effects in adult asthma: systematic review and meta-analysis. Eur Respir J
2006;28:960-7.
244. McCowan C, Hoskins G, Neville RG. Clinical symptoms and 'off-label' prescribing in
children with asthma. Br J Gen Pract 2007;57:220-2.
245. McCoy K, Shade DM, Irvin CG, et al. Predicting episodes of poor asthma control in
treated patients with asthma. J Allergy Clin Immunol 2006;118:1226-33.
246. McGill C, Malik G, Turner SW. Validation of a hand-held exhaled nitric oxide analyzer
for use in children. Pediatr Pulmonol 2006;41:1053-7.
247. Mehl-Madrona L, Kligler B, Silverman S, Lynton H, Merrell W. The impact of
acupuncture and craniosacral therapy interventions on clinical outcomes in adults with asthma.
Explore (NY) 2007;3:28-36.
248. Mehuys E, Van Bortel L, Annemans L, et al. Medication use and disease control of
asthmatic patients in Flanders: a cross-sectional community pharmacy study. Respir Med
2006;100:1407-14.
249. Meinero M, Coletta G, Dutto L, et al. Mechanical response to methacholine and deep
inspiration in supine men. J Appl Physiol 2007;102:269-75.
250. Menzies D, Nair A, Fardon T, Barnes M, Burns P, Lipworth B. An in vivo and in vitro
comparison of inhaled steroid delivery via a novel vortex actuator and a conventional valved
holding chamber. Ann Allergy Asthma Immunol 2007;98:471-9.
251. Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement:
Comparison with the "gold standard" technique. Chest 2007;131:410-4.
252. Miller MK, Lee JH, Blanc PD, et al. TENOR risk score predicts healthcare in adults with
severe or difficult-to-treat asthma. Eur Respir J 2006;28:1145-55.
253. Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor
of future exacerbations. Respir Med 2007;101:481-9.
254. Mita H, Turikisawa N, Yamada T, Taniguchi M. Quantification of leukotriene B4
glucuronide in human urine. Prostaglandins Other Lipid Mediat 2007;83:42-9.
255. Mohrenschlager M, Haberl VM, Kramer U, Behrendt H, Ring J. Early BCG and pertussis
vaccination and atopic diseases in 5- to 7-year-old preschool children from Augsburg, Germany:
results from the MIRIAM study. Pediatr Allergy Immunol 2007;18:5-9.
256. Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G. Effects of a leukotriene
receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy
Clin Immunol 2006;118:347-53.
257. Morell F, Genover T, Reyes L, Benaque E, Roger A, Ferrer J. [Monitoring of asthma
outpatients after adapting treatment to meet international guidelines]. Arch Bronconeumol
2007;43:29-35.
258. Morgenstern V, Zutavern A, Cyrys J, et al. Respiratory health and individual estimated
exposure to traffic-related air pollutants in a cohort of young children. Occup Environ Med
2007;64:8-16.
259. Mortimer K, Brown A, Feary J, et al. Dose-ranging study for trials of therapeutic
infection with Necator americanus in humans. Am J Trop Med Hyg 2006;75:914-20.
260. Mortimer KJ, Harrison TW, Tang Y, et al. Plasma concentrations of inhaled
corticosteroids in relation to airflow obstruction in asthma. Br J Clin Pharmacol 2006;62:412-9.
261. Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care
for adults in the United States as measured by adherence to recommended processes. Chest
2006;130:1844-50.
262. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of
hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006;60:762-9.
263. Munzenberger PJ, Hill MJ. Impact of an asthma-specific questionnaire on problem
identification and clinical and economic outcomes in ambulatory patients with persistent asthma.
J Am Pharm Assoc (2003) 2007;47:147-55.
264. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A. Secondary prevention of
asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind,
randomised, controlled study. Lancet 2006;368:754-62.
265. Nahin RL, Fitzpatrick AL, Williamson JD, Burke GL, Dekosky ST, Furberg C. Use of
herbal medicine and other dietary supplements in community-dwelling older people: Baseline
data from the ginkgo evaluation of memory study. J Am Geriatr Soc 2006;54:1725-35.
266. Najafizadeh K, Sohrab Pour H, Ghadyanee M, Shiehmorteza M, Jamali M, Majdzadeh S.
A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the
management of acute asthma. Emerg Med J 2007;24:317-21.
267. Nathan JA, Pearce L, Field C, et al. A randomized controlled trial of follow-up of
patients discharged from the hospital following acute asthma: best performed by specialist nurse
or doctor? Chest 2006;130:51-7.
268. Nathan RA, Finn AF, Jr., LaForce C, et al. Comparison of cetirizine-pseudoephedrine
and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma:
randomized, double-blind study. Ann Allergy Asthma Immunol 2006;97:389-96.
269. Nelson BW, Clark NM, Valerio MA, Houle CR, Brown RW, Brown C. Working with a
Head Start population with asthma: lessons learned. J Sch Health 2006;76:273-5.
270. Nelson WK, Fatima J, Houghton SG, et al. The malabsorptive very, very long limb
Roux-en-Y gastric bypass for super obesity: results in 257 patients. Surgery 2006;140:517-22,
discussion 22-3.
271. Ngiam NS, Chong SS, Shek LP, et al. Cystic fibrosis transmembrane conductance
regulator (CFTR) gene mutations in Asians with chronic pulmonary disease: a pilot study. J Cyst
Fibros 2006;5:159-64.
272. Nickmilder M, Bernard A. Ecological association between childhood asthma and
availability of indoor chlorinated swimming pools in Europe. Occup Environ Med 2007;64:3746.
273. Nieto A, Pamies R, Oliver F, Medina A, Caballero L, Mazon A. Montelukast improves
pulmonary function measured by impulse oscillometry in children with asthma (Mio study).
Respir Med 2006;100:1180-5.
274. Niggemann B, Jacobsen L, Dreborg S, et al. Five-year follow-up on the PAT study:
specific immunotherapy and long-term prevention of asthma in children. Allergy 2006;61:855-9.
275. Nikonorov MV, Boriak VP. [Updated assessment of efficacy of dry air radon baths of
different concentrations at the stage of medical rehabilitation of patients with bronchial asthma].
Vopr Kurortol Fizioter Lech Fiz Kult 2006:15-8.
276. Nishiyama O, Taniguchi H, Kondoh Y, et al. Comparison of the effects of tulobuterol
patch and salmeterol in moderate to severe asthma. Clin Exp Pharmacol Physiol 2006;33:101621.
277. Niu CK, Chen WY, Huang JL, Lue KH, Wang JY. Efficacy of sublingual
immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind,
randomized, and placebo-controlled study in Taiwan. Respir Med 2006;100:1374-83.
278. Nixon PA, Washburn LK, Schechter MS, O'Shea TM. Follow-up study of a randomized
controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on
pulmonary outcomes at age 8 to 11 years. J Pediatr 2007;150:345-50.
279. Norton SP, Pusic MV, Taha F, Heathcote S, Carleton BC. Effect of a clinical pathway on
the hospitalisation rates of children with asthma: a prospective study. Arch Dis Child
2007;92:60-6.
280. O'Connell O, Beckert L. Asthmatics: too drunk to drive? The time curve of exhaled
ethanol levels after use of Salamol in normal subjects. N Z Med J 2006;119:U2282.
281. Orbon KH, van der Gulden JW, Schermer TR, et al. Vocational and working career of
asthmatic adolescents is only slightly affected. Respir Med 2006;100:1163-73.
282. Owen CE. Immunoglobulin E: role in asthma and allergic disease: lessons from the
clinic. Pharmacol Ther 2007;113:121-33.
283. Ozbek OY, Turktas I, Bakirtas A, Bideci A. Evaluation of hypothalamic-pituitary-adrenal
axis suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic
hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid. J Pediatr
Endocrinol Metab 2006;19:1015-23.
284. Palma-Carlos AG, Santos AS, Branco-Ferreira M, et al. Clinical efficacy and safety of
preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic
patients. A double-blind, placebo-controlled study. Allergol Immunopathol (Madr) 2006;34:1948.
285. Palmer CN, Lipworth BJ, Lee S, Ismail T, Macgregor DF, Mukhopadhyay S. Arginine16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular
salmeterol. Thorax 2006;61:940-4.
286. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in
a single inhaler for mild asthma. N Engl J Med 2007;356:2040-52.
287. Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol
versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007;29:682-9.
288. Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis
and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy
2006;36:1161-7.
289. Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance
with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel
SLIT formulation during a year). Pediatr Allergy Immunol 2007;18:58-62.
290. Passalacqua G, Pasquali M, Ariano R, et al. Randomized double-blind controlled study
with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy
2006;61:849-54.
291. Pattaro C, Locatelli F, Sunyer J, de Marco R. Using the age at onset may increase the
reliability of longitudinal asthma assessment. J Clin Epidemiol 2007;60:704-11.
292. Pattenden S, Hoek G, Braun-Fahrlander C, et al. NO2 and children's respiratory
symptoms in the PATY study. Occup Environ Med 2006;63:828-35.
293. Pauli C, Fintelmann R, Klemens C, et al. [Polyposis nasi--improvement in quality of life
by the influence of leukotrien receptor antagonists]. Laryngorhinootologie 2007;86:282-6.
294. Pearlman D, Milgrom H, Till D, Ziehmer B. Effect of formoterol fumarate treatment on
exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol 2006;97:382-8.
295. Pearlman DS, van Adelsberg J, Philip G, et al. Onset and duration of protection against
exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma
Immunol 2006;97:98-104.
296. Pedersen S, Garcia Garcia ML, Manjra A, Theron I, Engelstatter R. A comparative study
of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children
with asthma. Pediatr Pulmonol 2006;41:954-61.
297. Peters SP, Anthonisen N, Castro M, et al. Randomized comparison of strategies for
reducing treatment in mild persistent asthma. N Engl J Med 2007;356:2027-39.
298. Petronella SA, Bricker SK, Perrotta D, Brown C, Brooks EG. Addressing asthma in
Texas: development of a school-based asthma surveillance program for Texas elementary
schools. J Sch Health 2006;76:227-34.
299. Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C. Assessment of sublingual
immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally
controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol
2007;18:47-57.
300. Philip G, Villaran C, Pearlman DS, Loeys T, Dass SB, Reiss TF. Protection against
exercise-induced bronchoconstriction two hours after a single oral dose of montelukast. J
Asthma 2007;44:213-7.
301. Pilette C, Nouri-Aria KT, Jacobson MR, et al. Grass pollen immunotherapy induces an
allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J
Immunol 2007;178:4658-66.
302. Pohunek P, Kuna P, Jorup C, De Boeck K. Budesonide/formoterol improves lung
function compared with budesonide alone in children with asthma. Pediatr Allergy Immunol
2006;17:458-65.
303. Polosa R. Critical appraisal of antileukotriene use in asthma management. Curr Opin
Pulm Med 2007;13:24-30.
304. Polosa R. Critical appraisal of antileukotriene use in asthma management. Curr Opin
Pulm Med 2007;13:24-30.
305. Ponsonby AL, Dwyer T, van der Mei I, et al. Asthma onset prior to multiple sclerosis and
the contribution of sibling exposure in early life. Clin Exp Immunol 2006;146:463-70.
306. Portnoy JM, Jennings D. Utilization patterns in an asthma intervention. Ann Allergy
Asthma Immunol 2006;97:S25-30.
307. Price D, Canonica GW, Dahl R, et al. ABS008: Asthma management and the PCP:
Findings of the global asthma physician and patient (GAPP) survey. Prim Care Respir J 2006.
308. Prieto L, Ferrer A, Domenech J, Perez-Frances C. Effect of challenge method on
sensitivity, reactivity, and maximal response to methacholine. Ann Allergy Asthma Immunol
2006;97:175-81.
309. Prieto L, Reig I, Rojas R, Ferrer A, Domenech J. The effect of challenge method on
sensitivity and reactivity to adenosine 5'-monophosphate in subjects with suspected asthma.
Chest 2006;130:1448-53.
310. Priftis KN, Anthracopoulos MB, Nikolaou-Papanagiotou A, et al. Increased sensitization
in urban vs. rural environment--rural protection or an urban living effect? Pediatr Allergy
Immunol 2007;18:209-16.
311. Priftis KN, Papadimitriou A, Anthracopoulos MB, et al. Adrenal function improves in
asthmatic children on inhaled steroids: a longitudinal study. Neuroimmunomodulation
2006;13:56-62.
312. Qaqundah PY, Sugerman RW, Ceruti E, et al. Efficacy and safety of fluticasone
propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a
randomized, double-blind, placebo-controlled study. J Pediatr 2006;149:663-70.
313. Raat H, Mangunkusumo RT, Mohangoo AD, Juniper EF, Van Der Lei J. Internet and
written respiratory questionnaires yield equivalent results for adolescents. Pediatr Pulmonol
2007;42:357-61.
314. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in
combination with formoterol for reliever therapy in asthma exacerbations: a randomised
controlled, double-blind study. Lancet 2006;368:744-53.
315. Rachiotis G, Savani R, Brant A, MacNeill SJ, Newman Taylor A, Cullinan P. Outcome
of occupational asthma after cessation of exposure: a systematic review. Thorax 2007;62:147-52.
316. Ragab S, Scadding GK, Lund VJ, Saleh H. Treatment of chronic rhinosinusitis and its
effects on asthma. Eur Respir J 2006;28:68-74.
317. Raghunath AS, Innes A, Norfolk L, et al. Difficulties in the interpretation of lung
function tests in the diagnosis of asthma and chronic obstructive pulmonary disease. J Asthma
2006;43:657-60.
318. Rahimi R, Nikfar S, Abdollahi M. Meta-analysis finds use of inhaled corticosteroids
during pregnancy safe: a systematic meta-analysis review. Hum Exp Toxicol 2006;25:447-52.
319. Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS. Adherence with
montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast
versus inhaled corticosteroid trial. J Allergy Clin Immunol 2007;119:916-23.
320. Rastogi D, Wang C, Lendor C, Rothman PB, Miller RL. T-helper type 2 polarization
among asthmatics during and following pregnancy. Clin Exp Allergy 2006;36:892-8.
321. Ravensberg AJ, Luijk B, Westers P, et al. The effect of a single inhaled dose of a VLA-4
antagonist on allergen-induced airway responses and airway inflammation in patients with
asthma. Allergy 2006;61:1097-103.
322. Razi C, Bakirtas A, Harmanci K, Turktas I, Erbas D. Effect of montelukast on symptoms
and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis. Ann
Allergy Asthma Immunol 2006;97:767-74.
323. Reisman J, Schachter HM, Dales RE, et al. Treating asthma with omega-3 fatty acids:
where is the evidence? A systematic review. BMC Complement Altern Med 2006;6:26.
324. Reti S. Ventolin to Salamol--a crossover study in New Zealand. N Z Med J
2006;119:U2276.
325. Richter K, Hartmann U, Metzenauer P, Magnussen H. Randomised trial comparing asneeded versus regular treatment with formoterol in patients with persistent asthma. Respir Med
2007;101:467-75.
326. Riiser A, Tjorhom A, Carlsen KH. The effect of formoterol inhalation on endurance
performance in hypobaric conditions. Med Sci Sports Exerc 2006;38:2132-7.
327. Roberts L, Roalfe A, Wilson S, Lester H. Physical health care of patients with
schizophrenia in primary care: a comparative study. Fam Pract 2007;24:34-40.
328. Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma
in children: a randomized controlled trial. Am J Respir Crit Care Med 2007;175:323-9.
329. Rogausch A, Kochen MM, Meineke C, Hennig J. Association between the BclI
glucocorticoid receptor polymorphism and smoking in a sample of patients with obstructive
airway disease. Addict Biol 2007;12:93-9.
330. Rusconi F, Galassi C, Forastiere F, et al. Maternal complications and procedures in
pregnancy and at birth and wheezing phenotypes in children. Am J Respir Crit Care Med
2007;175:16-21.
331. Sadof MD, Boschert KA, Brandt SJ, Motyl AP. An analysis of predictors of
sustainability efforts at the Inner-City Asthma Intervention sites: after the funding is gone. Ann
Allergy Asthma Immunol 2006;97:S31-5.
332. Saffar AS, Alphonse MP, Shan L, Hayglass KT, Simons FE, Gounni AS. IgE modulates
neutrophil survival in asthma: role of mitochondrial pathway. J Immunol 2007;178:2535-41.
333. Salo D, Tuel M, Lavery RF, Reischel U, Lebowitz J, Moore T. A randomized, clinical
trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous
nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma. J
Emerg Med 2006;31:371-6.
334. Sandel M, Wright RJ. When home is where the stress is: expanding the dimensions of
housing that influence asthma morbidity. Arch Dis Child 2006;91:942-8.
335. Sanders DL, Aronsky D. Biomedical informatics applications for asthma care: a
systematic review. J Am Med Inform Assoc 2006;13:418-27.
336. Schildcrout JS, Sheppard L, Lumley T, Slaughter JC, Koenig JQ, Shapiro GG. Ambient
air pollution and asthma exacerbations in children: an eight-city analysis. Am J Epidemiol
2006;164:505-17.
337. Schoemaker MJ, Swerdlow AJ, Auvinen A, et al. Medical history, cigarette smoking and
risk of acoustic neuroma: an international case-control study. Int J Cancer 2007;120:103-10.
338. Schuh S, Dick PT, Stephens D, et al. High-dose inhaled fluticasone does not replace oral
prednisolone in children with mild to moderate acute asthma. Pediatrics 2006;118:644-50.
339. Schultz K, Bergmann KC, Kenn K, et al. [Effectiveness of inpatient pulmonary
rehabilitation (AHB). Results of a multicenter prospective observation study]. Dtsch Med
Wochenschr 2006;131:1793-8.
340. Scott KM, Von Korff M, Ormel J, et al. Mental disorders among adults with asthma:
results from the World Mental Health Survey. Gen Hosp Psychiatry 2007;29:123-33.
341. Serrano J, Plaza V, Sureda B, et al. Alexithymia: a relevant psychological variable in
near-fatal asthma. Eur Respir J 2006;28:296-302.
342. Sestini P, Cappiello V, Aliani M, et al. Prescription bias and factors associated with
improper use of inhalers. J Aerosol Med 2006;19:127-36.
343. Shaaban R, Leynaert B, Soussan D, et al. Physical activity and bronchial
hyperresponsiveness: European Community Respiratory Health Survey II. Thorax 2007;62:40310.
344. Shah RV, Amin M, Sangwan S, Smaldone GC. Steroid effects on mucociliary clearance
in outpatient asthma. J Aerosol Med 2006;19:208-20.
345. Shaheen SO, Newson RB, Rayman MP, et al. Randomised, double blind, placebocontrolled trial of selenium supplementation in adult asthma. Thorax 2007;62:483-90.
346. Shedd AD, Peters JI, Wood P, et al. Impact of home environment characteristics on
asthma quality of life and symptom scores. J Asthma 2007;44:183-7.
347. Sheth K, Wasserman RL, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C.
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated
dose counter: Performance and patient satisfaction. Int J Clin Pract 2006;60:1218-24.
348. Shimizu Y, Dobashi K, Kobayashi S, et al. A proton pump inhibitor, lansoprazole,
ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease.
Tohoku J Exp Med 2006;209:181-9.
349. Shin HW, Schwindt CD, Aledia AS, et al. Exercise-induced bronchoconstriction alters
airway nitric oxide exchange in a pattern distinct from spirometry. Am J Physiol Regul Integr
Comp Physiol 2006;291:R1741-8.
350. Shreffler WG, Visness CM, Burger M, et al. Standardization and performance evaluation
of mononuclear cell cytokine secretion assays in a multicenter study. BMC Immunol 2006;7:29.
351. Sichletidis L, Chloros D, Spyratos D, et al. The validity of the diagnosis of chronic
obstructive pulmonary disease in general practice. Prim Care Respir J 2007;16:82-8.
352. Sieskiewicz A, Olszewska E, Rogowski M, Grycz E. Preoperative corticosteroid oral
therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with
severe nasal polyposis: a preliminary investigation. Ann Otol Rhinol Laryngol 2006;115:490-4.
353. Sinha S, Goldstein M, Penrod J, et al. Brief report: beta-blocker use among veterans with
systolic heart failure. J Gen Intern Med 2006;21:1306-9.
354. Slader CA, Reddel HK, Spencer LM, et al. Double blind randomised controlled trial of
two different breathing techniques in the management of asthma. Thorax 2006;61:651-6.
355. Slats AM, Sont JK, van Klink RH, Bel EH, Sterk PJ. Improvement in bronchodilation
following deep inspiration after a course of high-dose oral prednisone in asthma. Chest
2006;130:58-65.
356. Smith JR, Mugford M, Holland R, Noble MJ, Harrison BD. Psycho-educational
interventions for adults with severe or difficult asthma: a systematic review. J Asthma
2007;44:219-41.
357. Smith SR, Jaffe DM, Highstein G, Fisher EB, Trinkaus KM, Strunk RC. Asthma
coaching in the pediatric emergency department. Acad Emerg Med 2006;13:835-9.
358. Sole D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK. Prevalence of symptoms of
asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the
International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3. J Pediatr (Rio J)
2006;82:341-6.
359. Sorkness CA, Lemanske RF, Jr., Mauger DT, et al. Long-term comparison of 3 controller
regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J
Allergy Clin Immunol 2007;119:64-72.
360. Spencer S, Mayer B, Bendall KL, Bateman ED. Validation of a guideline-based
composite outcome assessment tool for asthma control. Respir Res 2007;8:26.
361. Splett PL, Erickson CD, Belseth SB, Jensen C. Evaluation and sustainability of the
healthy learners asthma initiative. J Sch Health 2006;76:276-82.
362. Srichana T, Suedee R, Tanmanee N, Muanpanarai D, Marriott C. The correlation of
urinary levels of albuterol and its metabolites isomers following inhalation from a dry powder
inhaler and in vitro particle size characterisation. Pulm Pharmacol Ther 2007;20:36-45.
363. Stallberg B, Pilman E, Skoogh BE, Hermansson BA. Potency ratio fluticasone propionate
(Flixotide Diskus)/budesonide (Pulmicort Turbuhaler). Respir Med 2007;101:610-5.
364. Stensrud T, Berntsen S, Carlsen KH. Humidity influences exercise capacity in subjects
with exercise-induced bronchoconstriction (EIB). Respir Med 2006;100:1633-41.
365. Stockert K, Schneider B, Porenta G, Rath R, Nissel H, Eichler I. Laser acupuncture and
probiotics in school age children with asthma: a randomized, placebo-controlled pilot study of
therapy guided by principles of Traditional Chinese Medicine. Pediatr Allergy Immunol
2007;18:160-6.
366. Stolz D, Pollak V, Chhajed PN, Gysin C, Pflimlin E, Tamm M. A randomized, placebocontrolled trial of bronchodilators for bronchoscopy in patients with COPD. Chest
2007;131:765-72.
367. Stordal K, Johannesdottir GB, Bentsen BS, Carlsen KC, Sandvik L. Asthma and
overweight are associated with symptoms of gastro-oesophageal reflux. Acta Paediatr
2006;95:1197-201.
368. Stout JW, Visness CM, Enright P, et al. Classification of asthma severity in children: the
contribution of pulmonary function testing. Arch Pediatr Adolesc Med 2006;160:844-50.
369. Strunk RC. Childhood Asthma Management Program: lessons learned. J Allergy Clin
Immunol 2007;119:36-42.
370. Strunk RC, Weiss ST, Yates KP, Tonascia J, Zeiger RS, Szefler SJ. Mild to moderate
asthma affects lung growth in children and adolescents. J Allergy Clin Immunol 2006;118:10407.
371. Sunyer J, Pekkanen J, Garcia-Esteban R, et al. Asthma score: predictive ability and risk
factors. Allergy 2007;62:142-8.
372. Sutcliffe A, Kaur D, Page S, et al. Mast cell migration to Th2 stimulated airway smooth
muscle from asthmatics. Thorax 2006;61:657-62.
373. Svanes C, Zock JP, Anto J, et al. Do asthma and allergy influence subsequent pet
keeping? An analysis of childhood and adulthood. J Allergy Clin Immunol 2006;118:691-8.
374. Sylvester KP, Patey RA, Broughton S, et al. Temporal relationship of asthma to acute
chest syndrome in sickle cell disease. Pediatr Pulmonol 2007;42:103-6.
375. Tabar AI, Anda M, Bonifazi F, et al. Specific immunotherapy with standardized latex
extract versus placebo in latex-allergic patients. Int Arch Allergy Immunol 2006;141:369-76.
376. Tan TN, Shek LP, Goh DY, Chew FT, Lee BW. Prevalence of asthma and comorbid
allergy symptoms in Singaporean preschoolers. Asian Pac J Allergy Immunol 2006;24:175-82.
377. Tan WC, Lamm CJ, Chen YZ, et al. Effectiveness of early budesonide intervention in
Caucasian versus Asian patients with asthma: 3-year results of the START study. Respirology
2006;11:767-75.
378. Telford K, Waters L, Vyas H, Manktelow BN, Draper ES, Marlow N. Respiratory
outcome in late childhood after neonatal continuous negative pressure ventilation. Arch Dis
Child Fetal Neonatal Ed 2007;92:F19-24.
379. Ternesten-Hasseus E, Lowhagen O, Millqvist E. Quality of life and capsaicin sensitivity
in patients with airway symptoms induced by chemicals and scents: a longitudinal study. Environ
Health Perspect 2007;115:425-9.
380. Thomas M, Sheran J, Smith N, Fonseca S, Lee AJ. AKL1, a botanical mixture for the
treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study. BMC
Pulm Med 2007;7:4.
381. Tohda Y, Tsuji F, Kubo H, Haraguchi R, Iwanaga T. Usefulness of QVAR for the
treatment of bronchial asthma--with and without use of an inhalation device. J Asthma
2006;43:613-8.
382. Torrent M, Sunyer J, Munoz L, et al. Early-life domestic aeroallergen exposure and IgE
sensitization at age 4 years. J Allergy Clin Immunol 2006;118:742-8.
383. Tsai CL, Clark S, Cydulka RK, Rowe BH, Camargo CA, Jr. Factors associated with
hospital admission among emergency department patients with chronic obstructive pulmonary
disease exacerbation. Acad Emerg Med 2007;14:6-14.
384. Tudorache V, Mihaicuta S, Potre R, Melcescu E. [Is Widal syndrome always a severe
disease?]. Pneumologia 2006;55:105-8.
385. Tug T, Godekmerdan A, Sari N, Karatas F, Erdem ES. Effects of supportive treatment
such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory
parameters in asthma patients. Clin Pharmacol Ther 2007;81:371-6.
386. Tunon-de-Lara JM, Laurent F, Giraud V, et al. Air trapping in mild and moderate asthma:
effect of inhaled corticosteroids. J Allergy Clin Immunol 2007;119:583-90.
387. Vagaggini B, Cianchetti S, Bartoli M, et al. Prednisone blunts airway neutrophilic
inflammatory response due to ozone exposure in asthmatic subjects. Respiration 2007;74:61-8.
388. Valenca AM, Falcao R, Freire RC, et al. The relationship between the severity of asthma
and comorbidities with anxiety and depressive disorders. Rev Bras Psiquiatr 2006;28:206-8.
389. Valovirta E, Jacobsen L, Ljorring C, Koivikko A, Savolainen J. Clinical efficacy and
safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006;61:117783.
390. van Dellen QM, Stronks K, Bindels PJ, Ory FG, Bruil J, van Aalderen WM. Predictors of
asthma control in children from different ethnic origins living in Amsterdam. Respir Med
2007;101:779-85.
391. van Merode T, Maas T, Twellaar M, Kester A, van Schayck CP. Gender-specific
differences in the prevention of asthma-like symptoms in high-risk infants. Pediatr Allergy
Immunol 2007;18:196-200.
392. van Veen IH, ten Brinke A, van der Linden AC, Rabe KF, Bel EH. Deficient alpha-1antitrypsin phenotypes and persistent airflow limitation in severe asthma. Respir Med
2006;100:1534-9.
393. Verbanck S, Schuermans D, Paiva M, Vincken W. The functional benefit of antiinflammatory aerosols in the lung periphery. J Allergy Clin Immunol 2006;118:340-6.
394. Virchow JC, Bachert C. Efficacy and safety of montelukast in adults with asthma and
allergic rhinitis. Respir Med 2006;100:1952-9.
395. Vlieg-Boerstra BJ, van der Heide S, Bijleveld CM, et al. Dietary assessment in children
adhering to a food allergen avoidance diet for allergy prevention. Eur J Clin Nutr 2006;60:138490.
396. Vollmer WM, Kirshner M, Peters D, et al. Use and impact of an automated telephone
outreach system for asthma in a managed care setting. Am J Manag Care 2006;12:725-33.
397. Volovitz B, Shkap R, Amir J, Calderon S, Varsano I, Nussinovitch M. Absence of tooth
staining with doxycycline treatment in young children. Clin Pediatr (Phila) 2007;46:121-6.
398. von Berg A, Koletzko S, Filipiak-Pittroff B, et al. Certain hydrolyzed formulas reduce the
incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant
Nutritional Intervention Study. J Allergy Clin Immunol 2007;119:718-25.
399. von Berg A, Kremer HJ, Ellers-Lenz B, et al. Peak inspiratory flow rates generated
through the Novolizer and the Turbuhaler dry powder inhaler devices by children with stable
asthma. J Aerosol Med 2007;20:50-8.
400. Walters EH, Gibson PG, Lasserson TJ, Walters JA. Long-acting beta2-agonists for
chronic asthma in adults and children where background therapy contains varied or no inhaled
corticosteroid. Cochrane Database Syst Rev 2007:CD001385.
401. Wang Y, O'Donnell CA, Mackay DF, Watt GC. Practice size and quality attainment
under the new GMS contract: a cross-sectional analysis. Br J Gen Pract 2006;56:830-5.
402. Warman K, Silver EJ, Wood PR. Asthma risk factor assessment: what are the needs of
inner-city families? Ann Allergy Asthma Immunol 2006;97:S11-5.
403. Warner LJ, Lumley MA, Casey RJ, et al. Health effects of written emotional disclosure in
adolescents with asthma: a randomized, controlled trial. J Pediatr Psychol 2006;31:557-68.
404. Waser M, Michels KB, Bieli C, et al. Inverse association of farm milk consumption with
asthma and allergy in rural and suburban populations across Europe. Clin Exp Allergy
2007;37:661-70.
405. Wasserman RL, Sheth K, Lincourt WR, Locantore NW, Rosenzweig JC, Crim C. Realworld assessment of a metered-dose inhaler with integrated dose counter. Allergy Asthma Proc
2006;27:486-92.
406. White A, Ludington E, Mehra P, Stevenson DD, Simon RA. Effect of leukotriene
modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol
2006;97:688-93.
407. Willems DC, Joore MA, Hendriks JJ, Wouters EF, Severens JL. Cost-effectiveness of
self-management in asthma: a systematic review of peak flow monitoring interventions. Int J
Technol Assess Health Care 2006;22:436-42.
408. Williams A, Henzgen M, Rajakulasingam K. Additional benefit of a third year of specific
grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis. Allerg Immunol
(Paris) 2007;39:123-6.
409. Wolthers OD. Short-term growth and adrenal function in children with asthma treated
with inhaled beclomethasone dipropionate hydrofluoroalkane-134a. Pediatr Allergy Immunol
2006;17:613-9.
410. Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients
with rhinoconjunctivitis. Allerg Immunol (Paris) 2006;38:355-60.
411. Yang IA, Savarimuthu S, Kim ST, Holloway JW, Bell SC, Fong KM. Geneenvironmental interaction in asthma. Curr Opin Allergy Clin Immunol 2007;7:75-82.
412. Yang Z, Yan WX, Cai H, et al. S100A12 provokes mast cell activation: a potential
amplification pathway in asthma and innate immunity. J Allergy Clin Immunol 2007;119:10614.
413. Yoon Y, Park HD, Park KU, Kim JQ, Chang YS, Song J. Associations between CYP2E1
promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios. Eur J Clin
Pharmacol 2006;62:627-31.
414. Yorke J, Fleming SL, Shuldham C. A systematic review of psychological interventions
for children with asthma. Pediatr Pulmonol 2007;42:114-24.
415. Yorke J, Fleming SL, Shuldham C. Psychological interventions for adults with asthma: a
systematic review. Respir Med 2007;101:1-14.
416. Yuksel H, Berardino L, Yuksel D, Yilmaz O, Burak Z. Improved efficacy of aerosol
delivery to distal airways in pediatric subjects using a new spacer mouth-mask. Allerg Immunol
(Paris) 2007;39:64-8.
417. Zapke M, Topf HG, Zenker M, et al. Magnetic resonance lung function--a breakthrough
for lung imaging and functional assessment? A phantom study and clinical trial. Respir Res
2006;7:106.
418. Zar HJ, Streun S, Levin M, Weinberg EG, Swingler GH. Randomised controlled trial of
the efficacy of a metered dose inhaler with bottle spacer for bronchodilator treatment in acute
lower airway obstruction. Arch Dis Child 2007;92:142-6.
419. Zhang WP. [Effects of acupuncture on clinical symptoms and pulmonary function in the
patient of bronchial asthma]. Zhongguo Zhen Jiu 2006;26:763-7.
420. Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Szymanski W, Skiepko R. Effect
of ciclesonide and fluticasone on exhaled nitric oxide in patients with mild allergic asthma.
Respir Med 2006;100:1651-6.
421. Zuskin E, Mustajbegovic J, Schachter EN, et al. Respiratory findings in a nursing home
population. Arch Gerontol Geriatr 2007;44:153-61.